Cargando…
Optimization study of plasmonic cell fusion
Artificial cell fusion often serves as a valuable tool for studying different applications in biology and medicine, including natural development, immune response, cancer metastasis and production of therapeutic molecules. Plasmonic cell fusion, a technique that uses specific cell labeling by gold n...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065096/ https://www.ncbi.nlm.nih.gov/pubmed/35504928 http://dx.doi.org/10.1038/s41598-022-11168-x |
_version_ | 1784699509653110784 |
---|---|
author | Belansky, Julia Yelin, Dvir |
author_facet | Belansky, Julia Yelin, Dvir |
author_sort | Belansky, Julia |
collection | PubMed |
description | Artificial cell fusion often serves as a valuable tool for studying different applications in biology and medicine, including natural development, immune response, cancer metastasis and production of therapeutic molecules. Plasmonic cell fusion, a technique that uses specific cell labeling by gold nanoparticles and resonant femtosecond pulse irradiation for fusing neighboring cells, has been demonstrated useful for such applications, allowing high cell specificity and an overall low toxicity. Despite these advantages, the numerous experimental factors contributing to plasmonic fusion have often led to subpar fusion efficiencies, requiring repeated experiments and extensive calibration protocols for achieving optimal results. In this work we present a study that aims to improve the overall performance of plasmonic cell fusion in terms of fusion efficiency and cell viability. By varying the pulse fluence, nanoparticle concentration, incubation times, and culture handling protocols, we demonstrate up to 100% fusion of malignant epithelial cells across the entire irradiated area of the culture. We also show that some of the smaller cells may stay viable for up to several days. The results would allow plasmonic fusion to play a key role in numerous studies and applications that require specific, high-efficiency cell–cell fusion. |
format | Online Article Text |
id | pubmed-9065096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-90650962022-05-04 Optimization study of plasmonic cell fusion Belansky, Julia Yelin, Dvir Sci Rep Article Artificial cell fusion often serves as a valuable tool for studying different applications in biology and medicine, including natural development, immune response, cancer metastasis and production of therapeutic molecules. Plasmonic cell fusion, a technique that uses specific cell labeling by gold nanoparticles and resonant femtosecond pulse irradiation for fusing neighboring cells, has been demonstrated useful for such applications, allowing high cell specificity and an overall low toxicity. Despite these advantages, the numerous experimental factors contributing to plasmonic fusion have often led to subpar fusion efficiencies, requiring repeated experiments and extensive calibration protocols for achieving optimal results. In this work we present a study that aims to improve the overall performance of plasmonic cell fusion in terms of fusion efficiency and cell viability. By varying the pulse fluence, nanoparticle concentration, incubation times, and culture handling protocols, we demonstrate up to 100% fusion of malignant epithelial cells across the entire irradiated area of the culture. We also show that some of the smaller cells may stay viable for up to several days. The results would allow plasmonic fusion to play a key role in numerous studies and applications that require specific, high-efficiency cell–cell fusion. Nature Publishing Group UK 2022-05-03 /pmc/articles/PMC9065096/ /pubmed/35504928 http://dx.doi.org/10.1038/s41598-022-11168-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Belansky, Julia Yelin, Dvir Optimization study of plasmonic cell fusion |
title | Optimization study of plasmonic cell fusion |
title_full | Optimization study of plasmonic cell fusion |
title_fullStr | Optimization study of plasmonic cell fusion |
title_full_unstemmed | Optimization study of plasmonic cell fusion |
title_short | Optimization study of plasmonic cell fusion |
title_sort | optimization study of plasmonic cell fusion |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065096/ https://www.ncbi.nlm.nih.gov/pubmed/35504928 http://dx.doi.org/10.1038/s41598-022-11168-x |
work_keys_str_mv | AT belanskyjulia optimizationstudyofplasmoniccellfusion AT yelindvir optimizationstudyofplasmoniccellfusion |